Business News


Eyes Catching Stocks: Sysorex Global Holdings Corp. (NASDAQ:SYRX), Sears Holdings Corporation (NASDAQ:SHLD), Iridium Communications Inc. (NASDAQ:IRDM)

Big data software solutions and infrastructure provider, Sysorex Global Holdings Corp. (NASDAQ:SYRX) released that it has completed the

Tech News


Unexpected Moves in Focus: FirstEnergy Corp. (NYSE:FE), Bellatrix Exploration Ltd. (NYSE:BXE), BankUnited, Inc. (NYSE:BKU)

A subsidiary of FirstEnergy Corp. (NYSE:FE) [Trend Analysis] announced its Perry Nuclear Power Plant in Perry, Ohio, FirstEnergy Nuclear

General News

stock news

FuelCell Energy (NASDAQ:FCEL) Swings on Major Declaration- Golar LNG (NASDAQ:GLNG), FedEx (NYSE:FDX), Archer-Daniels-Midland (NYSE:ADM)

FuelCell Energy Inc (NASDAQ:FCEL) (Full FREE Analysis of FCEL And Be Sure To Notice The Intermediate Period) released its fourth quarter



Dominion Resources (NYSE:D) Swings on Declaration- Cablevision Systems (NYSE:CVC), GlaxoSmithKline (NYSE:GSK), Harris (NYSE:HRS)

Dominion Resources, Inc. (NYSE:D) released that its fourth quarter earnings of $0.84 a share, excluding non-recurring items. The firm



Stocks on Boom: GrafTech International Ltd. (NYSE:GTI), Rio Tinto plc (NYSE:RIO), DIRECTV (NASDAQ:DTV)

A maker of carbon and graphite products, GrafTech International Ltd. (NYSE:GTI) released that operating cash flow will probably be at



Johnson & Johnson (NYSE:JNJ) Under Pressure on New Entrance- Silvercorp Metals (NYSE:SVM), Medtronic (NYSE:MDT), The Charles Schwab (NYSE:SCHW)

Johnson & Johnson (NYSE:JNJ) dropped around 2% in last session as Janssen Pharma declared that it will invest in a novel scientific approach, called disease interception, to find ways to intercept type 1 diabetes using new diagnostic and pre-disease intervention strategies. This new approach to T1D is the initial in a series of disease areas to be tackled as part of Janssen's newly announced Disease Interception Accelerator, an autonomous incubator-like group that seeks to identify the root causes of disease and enable the development of interventions that stop the progression to disease. Whereas, shares of Johnson & Johnson (NYSE:JNJ) traded down of -1.93% to finished at USD98.44 with market capitalization